Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
Abstract
The Advanced Prostate Cancer Consensus Conference provides a forum to discuss and debate current diagnostic and treatment options for patients with advanced prostate cancer. The conference, which has been held three times since 2015, aims to share the knowledge of world experts in prostate cancer management with health care providers worldwide. At the end of the conference, an expert panel discusses and votes on predefined consensus questions that target the most clinically relevant areas of advanced prostate cancer treatment. The results of the voting provide a practical guide to help clinicians discuss therapeutic options with patients as part of shared and multidisciplinary decision making.
MeSH terms
Funding
- Prostate Cancer Foundation
- Amgen
- Bristol-Myers Squibb
- AstraZeneca
- Sanofi
- Movember Foundation
- European School of Oncology
- Astellas Pharma
- Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung
- Swiss Cancer Research Foundation
- Sanofi Genzyme
- Medical Research Council
- National Health and Medical Research Council
How this paper connects to the literature. Drag to explore, click any node to open that paper.
